Towercrest Capital Management Curis Inc Transaction History

Towercrest Capital Management

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 13, 2021	SELL	$7.45 - $16.27 $149,000 - $325,400	-20,000 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$8.78 - $12.8 $175,600 - $256,000	20,000 New	20,000 $226,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $495M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Towercrest Capital Management, based on Form 13F filings with the SEC.

Stay updated on Towercrest Capital Management with notifications on news.